XSHG600739
Market cap2.01bUSD
Jan 09, Last price
9.59CNY
1D
-1.53%
1Q
-19.70%
Jan 2017
-46.18%
Name
Liaoning Cheng Da Co Ltd
Chart & Performance
Profile
Liaoning Cheng Da Co., Ltd. engages in trading, medicine and medical care, financial investment, and energy development businesses in China and internationally. The company trades in textile and apparel, chemical products, coal, aquatic products, timber, and steel; and offers medical insurance. It is also involved in the research, development, production, and marketing of human and veterinary vaccines; pharmaceutical retail and wholesale, and logistics distribution activities; the provision of medical enterprise management consulting; and sale of medical equipment. In addition, the company offers medical technology, computer hardware and software technology development, technology consulting and transfer, and technical services. Further, it engages in securities and fund activities; and the development of oil shale projects. Liaoning Cheng Da Co., Ltd. was founded in 1991 and is headquartered in Dalian, China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
Income | |||||||||
Revenues | 10,782,827 -25.97% | 14,564,675 -20.73% | |||||||
Cost of revenue | 9,882,301 | 12,820,987 | |||||||
Unusual Expense (Income) | |||||||||
NOPBT | 900,525 | 1,743,689 | |||||||
NOPBT Margin | 8.35% | 11.97% | |||||||
Operating Taxes | 121,457 | 260,096 | |||||||
Tax Rate | 13.49% | 14.92% | |||||||
NOPAT | 779,068 | 1,483,593 | |||||||
Net income | 233,083 -80.95% | 1,223,555 -43.34% | |||||||
Dividends | (896,832) | ||||||||
Dividend yield | 4.90% | ||||||||
Proceeds from repurchase of equity | (130,186) | ||||||||
BB yield | 0.71% | ||||||||
Debt | |||||||||
Debt current | 7,121,544 | 7,103,171 | |||||||
Long-term debt | 3,348,969 | 4,509,154 | |||||||
Deferred revenue | 118,037 | 129,449 | |||||||
Other long-term liabilities | 173,910 | 212,793 | |||||||
Net debt | (27,051,460) | (26,727,836) | |||||||
Cash flow | |||||||||
Cash from operating activities | 646,984 | 1,427,341 | |||||||
CAPEX | (703,051) | ||||||||
Cash from investing activities | (1,497,353) | 3,314,586 | |||||||
Cash from financing activities | (1,814,163) | ||||||||
FCF | 1,344,005 | 1,930,084 | |||||||
Balance | |||||||||
Cash | 7,088,514 | 8,768,866 | |||||||
Long term investments | 30,433,458 | 29,571,295 | |||||||
Excess cash | 36,982,831 | 37,611,927 | |||||||
Stockholders' equity | 22,536,261 | 28,016,790 | |||||||
Invested Capital | 19,818,513 | 16,087,088 | |||||||
ROIC | 4.34% | 9.05% | |||||||
ROCE | 2.13% | 3.95% | |||||||
EV | |||||||||
Common stock shares outstanding | 1,553,886 | 1,524,577 | |||||||
Price | 11.78 -6.43% | 12.59 -35.50% | |||||||
Market cap | 18,304,780 -4.63% | 19,194,419 -35.72% | |||||||
EV | (5,917,747) | (4,013,684) | |||||||
EBITDA | 1,255,386 | 2,123,233 | |||||||
EV/EBITDA | |||||||||
Interest | 5,626 | 656,792 | |||||||
Interest/NOPBT | 0.62% | 37.67% |